These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

254 related articles for article (PubMed ID: 28774760)

  • 1. Dosimetric comparison of rectal-sparing capabilities of rectal balloon vs injectable spacer gel in stereotactic body radiation therapy for prostate cancer: lessons learned from prospective trials.
    Jones RT; Hassan Rezaeian N; Desai NB; Lotan Y; Jia X; Hannan R; Kim DWN; Hornberger B; Dubas J; Laine AM; Zelefsky MJ; Timmerman RD; Folkert MR
    Med Dosim; 2017 Winter; 42(4):341-347. PubMed ID: 28774760
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A novel model to correlate hydrogel spacer placement, perirectal space creation, and rectum dosimetry in prostate stereotactic body radiotherapy.
    Hwang ME; Black PJ; Elliston CD; Wolthuis BA; Smith DR; Wu CC; Wenske S; Deutsch I
    Radiat Oncol; 2018 Oct; 13(1):192. PubMed ID: 30285812
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Rectal wall sparing by dosimetric effect of rectal balloon used during intensity-modulated radiation therapy (IMRT) for prostate cancer.
    Teh BS; Dong L; McGary JE; Mai WY; Grant W; Butler EB
    Med Dosim; 2005; 30(1):25-30. PubMed ID: 15749008
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Volumetric-modulated arc stereotactic body radiotherapy for prostate cancer: dosimetric impact of an increased near-maximum target dose and of a rectal spacer.
    Ruggieri R; Naccarato S; Stavrev P; Stavreva N; Fersino S; Giaj Levra N; Mazzola R; Mancosu P; Scorsetti M; Alongi F
    Br J Radiol; 2015 Oct; 88(1054):20140736. PubMed ID: 26235142
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Comparison of two different rectal spacers in prostate cancer external beam radiotherapy in terms of rectal sparing and volume consistency.
    Wolf F; Gaisberger C; Ziegler I; Krenn E; Scherer P; Hruby S; Schätz T; Forstner R; Holzinger J; Vaszi A; Kametriser G; Steininger P; Deutschmann H; Sedlmayer F
    Radiother Oncol; 2015 Aug; 116(2):221-5. PubMed ID: 26232129
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Rectal spacer hydrogel in 1.5T MR-guided and daily adapted SBRT for prostate cancer: dosimetric analysis and preliminary patient-reported outcomes.
    Alongi F; Rigo M; Figlia V; Cuccia F; Giaj-Levra N; Nicosia L; Ricchetti F; Vitale C; Sicignano G; De Simone A; Naccarato S; Ruggieri R; Mazzola R
    Br J Radiol; 2021 Jan; 94(1117):20200848. PubMed ID: 33095659
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Impact of hydrogel peri-rectal spacer insertion on prostate gland intra-fraction motion during 1.5 T MR-guided stereotactic body radiotherapy.
    Cuccia F; Mazzola R; Nicosia L; Figlia V; Giaj-Levra N; Ricchetti F; Rigo M; Vitale C; Mantoan B; De Simone A; Sicignano G; Ruggieri R; Cavalleri S; Alongi F
    Radiat Oncol; 2020 Jul; 15(1):178. PubMed ID: 32698843
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Dosimetric implications of an injection of hyaluronic acid for preserving the rectal wall in prostate stereotactic body radiation therapy.
    Chapet O; Udrescu C; Tanguy R; Ruffion A; Fenoglietto P; Sotton MP; Devonec M; Colombel M; Jalade P; Azria D
    Int J Radiat Oncol Biol Phys; 2014 Feb; 88(2):425-32. PubMed ID: 24411613
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Dosimetric feasibility of neurovascular bundle-sparing stereotactic body radiotherapy with periprostatic hydrogel spacer for localized prostate cancer to preserve erectile function.
    Hwang ME; Mayeda M; Shaish H; Elliston CD; Spina CS; Wenske S; Deutsch I
    Br J Radiol; 2021 Mar; 94(1119):20200433. PubMed ID: 33586999
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Urethra-sparing stereotactic body radiotherapy for prostate cancer: how much can the rectal wall dose be reduced with or without an endorectal balloon?
    Dubouloz A; Rouzaud M; Tsvang L; Verbakel W; Björkqvist M; Linthout N; Lencart J; Pérez-Moreno JM; Ozen Z; Escude L; Zilli T; Miralbell R
    Radiat Oncol; 2018 Jun; 13(1):114. PubMed ID: 29921291
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Ion therapy of prostate cancer: daily rectal dose reduction by application of spacer gel.
    Rucinski A; Brons S; Richter D; Habl G; Debus J; Bert C; Haberer T; Jäkel O
    Radiat Oncol; 2015 Feb; 10():56. PubMed ID: 25886457
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A dosimetric comparison of ultra-hypofractionated passively scattered proton radiotherapy and stereotactic body radiotherapy (SBRT) in the definitive treatment of localized prostate cancer.
    Kole TP; Nichols RC; Lei S; Wu B; Huh SN; Morris CG; Lee S; Tong M; Mendenhall NP; Dritschilo A; Collins SP
    Acta Oncol; 2015 Jun; 54(6):825-31. PubMed ID: 25227898
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Dosimetric and deformation effects of image-guided interventions during stereotactic body radiation therapy of the prostate using an endorectal balloon.
    Jones BL; Gan G; Diot Q; Kavanagh B; Timmerman RD; Miften M
    Med Phys; 2012 Jun; 39(6):3080-8. PubMed ID: 22755693
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Dosimetric benefits of hemigland stereotactic body radiotherapy for prostate cancer: implications for focal therapy.
    Kishan AU; Park SJ; King CR; Roberts K; Kupelian PA; Steinberg ML; Kamrava M
    Br J Radiol; 2015; 88(1056):20150658. PubMed ID: 26463234
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Is an Endorectal Balloon Beneficial for Rectal Sparing after Spacer Implantation in Prostate Cancer Patients Treated with Hypofractionated Intensity-Modulated Proton Beam Therapy? A Dosimetric and Radiobiological Comparison Study.
    Ahmad Khalil D; Wulff J; Jazmati D; Geismar D; Bäumer C; Kramer PH; Steinmeier T; Schleithoff SS; Tschirdewahn S; Hadaschik B; Timmermann B
    Curr Oncol; 2023 Jan; 30(1):758-768. PubMed ID: 36661707
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Interfraction Anatomical Variability Can Lead to Significantly Increased Rectal Dose for Patients Undergoing Stereotactic Body Radiotherapy for Prostate Cancer.
    Wahl M; Descovich M; Shugard E; Pinnaduwage D; Sudhyadhom A; Chang A; Roach M; Gottschalk A; Chen J
    Technol Cancer Res Treat; 2017 Apr; 16(2):178-187. PubMed ID: 27199276
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Prostate seed implantation using 3D-computer assisted intraoperative planning vs. a standard look-up nomogram: Improved target conformality with reduction in urethral and rectal wall dose.
    Raben A; Chen H; Grebler A; Geltzeiler J; Geltzeiler M; Keselman I; Litvin S; Sim S; Hanlon A; Yang J
    Int J Radiat Oncol Biol Phys; 2004 Dec; 60(5):1631-8. PubMed ID: 15590195
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Dosimetric impacts of endorectal balloon in CyberKnife stereotactic body radiation therapy (SBRT) for early-stage prostate cancer.
    Xiang HF; Lu HM; Efstathiou JA; Zietman AL; De Armas R; Harris K; Bloch BN; Qureshi MM; Keohan S; Hirsch AE
    J Appl Clin Med Phys; 2017 May; 18(3):37-43. PubMed ID: 28407345
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Strict bladder filling and rectal emptying during prostate SBRT: Does it make a dosimetric or clinical difference?
    Byun DJ; Gorovets DJ; Jacobs LM; Happersett L; Zhang P; Pei X; Burleson S; Zhang Z; Hunt M; McBride S; Kollmeier MA; Zelefsky MJ
    Radiat Oncol; 2020 Oct; 15(1):239. PubMed ID: 33066781
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Dosimetric predictors for genitourinary toxicity in MR-guided stereotactic body radiation therapy (SBRT): Substructure with fraction-wise analysis.
    Pham J; Neilsen BK; Liu H; Cao M; Yang Y; Sheng K; Ma TM; Kishan AU; Ruan D
    Med Phys; 2024 Jan; 51(1):612-621. PubMed ID: 38055353
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.